126 related articles for article (PubMed ID: 34633743)
1. Mitosis-Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy.
Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
Cancer Cytopathol; 2022 Feb; 130(2):128-135. PubMed ID: 34633743
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma: Application of International Neuroblastoma Pathology Classification on fine needle aspiration cytology smears.
Rastogi K; Mahajan N; Khatri A; Khan NA
Indian J Pathol Microbiol; 2022; 65(2):387-391. PubMed ID: 35435376
[TBL] [Abstract][Full Text] [Related]
3.
Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
J Clin Pathol; 2023 Sep; 76(9):599-605. PubMed ID: 35414524
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
5. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
6. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
[TBL] [Abstract][Full Text] [Related]
7. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
8. MIB-1 Index as a Surrogate for Mitosis-Karyorrhexis Index in Neuroblastoma.
Atikankul T; Atikankul Y; Santisukwongchote S; Marrano P; Shuangshoti S; Thorner PS
Am J Surg Pathol; 2015 Aug; 39(8):1054-60. PubMed ID: 26171918
[TBL] [Abstract][Full Text] [Related]
9. Automated Tumor Count for Mitosis-Karyorrhexis Index Determination in Neuroblastoma Using Whole Slide Image and Qupath, an Image Analytic Software.
Yu G; Yu C; Xie F; He M
Pediatr Dev Pathol; 2022; 25(5):526-537. PubMed ID: 35570824
[TBL] [Abstract][Full Text] [Related]
10. Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology.
Behera G; Chhabra G; Mishra P; Sable M
Diagn Cytopathol; 2020 May; 48(5):464-474. PubMed ID: 32043835
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group.
Joshi VV; Chatten J; Sather HN; Shimada H
Mod Pathol; 1991 Mar; 4(2):139-47. PubMed ID: 2047378
[TBL] [Abstract][Full Text] [Related]
12. Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group.
Joshi VV; Rao PV; Cantor AB; Altshuler G; Shuster JJ; Castleberry RP
Cancer; 1996 Apr; 77(8):1582-8. PubMed ID: 8608547
[TBL] [Abstract][Full Text] [Related]
13. The relationship between contrast-enhanced computed tomography radiomics features and mitosis karyorrhexis index in neuroblastoma.
Chen X; Wang H; Xia Y; Shi F; He L; Liu E
Discov Oncol; 2024 Jun; 15(1):201. PubMed ID: 38822860
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors: Proposal for a cytology prognostic score.
Klijanienko J; Couturier J; Brisse H; Pierron G; Fréneaux P; Berger F; Maciorowski Z; Sastre-Garau X; Michon J; Schleiermacher G
Cancer Cytopathol; 2011 Dec; 119(6):411-23. PubMed ID: 21774092
[TBL] [Abstract][Full Text] [Related]
15. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
[TBL] [Abstract][Full Text] [Related]
17. Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours.
Uccini S; Colarossi C; Scarpino S; Boldrini R; Natali PG; Nicotra MR; Perla FM; Mannarino O; Altavista P; Boglino C; Cappelli CA; Cozzi D; Donfrancesco A; Kokai G; Losty PD; McDowell HP; Dominici C
Br J Cancer; 2006 Jul; 95(1):49-55. PubMed ID: 16755292
[TBL] [Abstract][Full Text] [Related]
18. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.
Thompson D; Vo KT; London WB; Fischer M; Ambros PF; Nakagawara A; Brodeur GM; Matthay KK; DuBois SG
Cancer; 2016 Mar; 122(6):935-45. PubMed ID: 26709890
[TBL] [Abstract][Full Text] [Related]
19. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
Ambros IM; Hata J; Joshi VV; Roald B; Dehner LP; Tüchler H; Pötschger U; Shimada H
Cancer; 2002 Mar; 94(5):1574-83. PubMed ID: 11920516
[TBL] [Abstract][Full Text] [Related]
20. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
